华兰疫苗：公司已签发流感疫苗批次为55批

Core Viewpoint - The company, Hualan Vaccine, has reported a significant increase in the awareness of the public regarding flu vaccination, leading to a rapid consumption of its four-valent flu virus split vaccine inventory [1] Group 1: Company Performance - Hualan Vaccine has issued a total of 55 batches of flu vaccines, ranking among the top in China for batch issuance [1] - The company has been working overtime to increase production and repackaging of the four-valent flu virus split vaccine to meet market demand [1] Group 2: Market Demand - Since October, particularly in November, there has been a notable rise in public awareness and demand for flu vaccinations [1] - The company has submitted applications for batch issuance of additional four-valent flu virus split vaccines, which are expected to be released to the market soon after approval [1]